- Home
- BYFC vs CLSD Comparison
BYFC vs CLSD Comparison
Compare BYFC & CLSD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYFC
- CLSD
- Stock Information
- Founded
- BYFC 1946
- CLSD 2011
- Country
- BYFC United States
- CLSD United States
- Employees
- BYFC N/A
- CLSD N/A
- Industry
- BYFC Savings Institutions
- CLSD Biotechnology: Pharmaceutical Preparations
- Sector
- BYFC Finance
- CLSD Health Care
- Exchange
- BYFC Nasdaq
- CLSD Nasdaq
- Market Cap
- BYFC 67.5M
- CLSD 68.4M
- IPO Year
- BYFC 1996
- CLSD 2016
- Fundamental
- Price
- BYFC $7.65
- CLSD $4.31
- Analyst Decision
- BYFC
- CLSD Hold
- Analyst Count
- BYFC 0
- CLSD 4
- Target Price
- BYFC N/A
- CLSD $65.00
- AVG Volume (30 Days)
- BYFC 2.1K
- CLSD 75.7K
- Earning Date
- BYFC 10-28-2025
- CLSD 11-11-2025
- Dividend Yield
- BYFC N/A
- CLSD N/A
- EPS Growth
- BYFC N/A
- CLSD N/A
- EPS
- BYFC N/A
- CLSD N/A
- Revenue
- BYFC $33,412,000.00
- CLSD $4,166,000.00
- Revenue This Year
- BYFC N/A
- CLSD $98.20
- Revenue Next Year
- BYFC N/A
- CLSD $213.77
- P/E Ratio
- BYFC N/A
- CLSD N/A
- Revenue Growth
- BYFC N/A
- CLSD N/A
- 52 Week Low
- BYFC $5.71
- CLSD $3.32
- 52 Week High
- BYFC $9.46
- CLSD $24.75
- Technical
- Relative Strength Index (RSI)
- BYFC 54.66
- CLSD 70.01
- Support Level
- BYFC $7.18
- CLSD $4.07
- Resistance Level
- BYFC $7.85
- CLSD $4.50
- Average True Range (ATR)
- BYFC 0.17
- CLSD 0.33
- MACD
- BYFC 0.04
- CLSD -0.06
- Stochastic Oscillator
- BYFC 72.54
- CLSD 71.28
About BYFC Broadway Financial Corporation
Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.
About CLSD Clearside Biomedical Inc.
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing a proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina, or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.